Literature DB >> 21350196

Apolipoprotein E induces antiinflammatory phenotype in macrophages.

Daniel Baitsch1, Hans H Bock, Thomas Engel, Ralph Telgmann, Carsten Müller-Tidow, Georg Varga, Martine Bot, Joachim Herz, Horst Robenek, Arnold von Eckardstein, Jerzy-Roch Nofer.   

Abstract

OBJECTIVE: Apolipoprotein E (apoE) exerts potent antiinflammatory effects. Here, we investigated the effect of apoE on the functional phenotype of macrophages. METHODS AND
RESULTS: Human apoE receptors very-low-density lipoprotein receptor (VLDL-R) and apoE receptor-2 (apoER2) were stably expressed in RAW264.7 mouse macrophages. In these cells, apoE downregulated markers of the proinflammatory M1 phenotype (inducible nitric oxide synthase, interleukin [IL]-12, macrophage inflammatory protein-1α) but upregulated markers of the antiinflammatory M2 phenotype (arginase I, SOCS3, IL-1 receptor antagonist [IL-1RA]). In addition, M1 macrophage responses (migration, generation of reactive oxygen species, antibody-dependent cell cytotoxicity, phagocytosis), as well as poly(I:C)- or interferon-γ-induced production of proinflammatory cytokines; cyclooxygenase-2 expression; and activation of nuclear factor-κB, IκB, and STAT1, were suppressed in VLDL-R- or apoER2-expressing cells. Conversely, the suppression of the M2 phenotype and the enhanced response to poly(I:C) were observed in apoE-producing bone marrow macrophages derived from VLDL-R-deficient mice but not wild-type or low-density lipoprotein receptor-deficient mice. The modulatory effects of apoE on macrophage polarization were inhibited in apoE receptor-expressing RAW264.7 cells exposed to SB220025, a p38 mitogen-activated protein kinase inhibitor, and PP1, a tyrosine kinase inhibitor. Accordingly, apoE induced tyrosine kinase-dependent activation of p38 mitogen-activated protein kinase in VLDL-R- or apoER2-expressing macrophages. Under in vivo conditions, apoE-/- mice transplanted with apoE-producing wild-type bone marrow showed increased plasma IL-1RA levels, and peritoneal macrophages of transplanted animals were shifted to the M2 phenotype (increased IL-1RA production and CD206 expression).
CONCLUSIONS: ApoE signaling via VLDL-R or apoER2 promotes macrophage conversion from the proinflammatory M1 to the antiinflammatory M2 phenotype. This effect may represent a novel antiinflammatory activity of apoE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350196      PMCID: PMC3529398          DOI: 10.1161/ATVBAHA.111.222745

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  38 in total

1.  Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels.

Authors:  Lili Bai; Karen Gabriels; Erwin Wijnands; Mat Rousch; Mat J A P Daemen; J W Cohen Tervaert; Erik A L Biessen; Sylvia Heeneman
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development.

Authors:  T P Hiltunen; J S Luoma; T Nikkari; S Ylä-Herttuala
Journal:  Circulation       Date:  1998-03-24       Impact factor: 29.690

3.  Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry.

Authors:  H A Multhaupt; M E Gåfvels; K Kariko; H Jin; C Arenas-Elliot; B I Goldman; J F Strauss; B Angelin; M J Warhol; K R McCrae
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

4.  Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.

Authors:  S Fazio; V R Babaev; A B Murray; A H Hasty; K J Carter; L A Gleaves; J B Atkinson; M F Linton
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions.

Authors:  K Nakazato; T Ishibashi; J Shindo; M Shiomi; Y Maruyama
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

6.  The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.

Authors:  D D Donaldson; M J Whitters; L J Fitz; T Y Neben; H Finnerty; S L Henderson; R M O'Hara; D R Beier; K J Turner; C R Wood; M Collins
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

7.  Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo.

Authors:  S E Roselaar; A Daugherty
Journal:  J Lipid Res       Date:  1998-09       Impact factor: 5.922

8.  Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor.

Authors:  P K Frykman; M S Brown; T Yamamoto; J L Goldstein; J Herz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Authors:  K Brand; S Page; G Rogler; A Bartsch; R Brandl; R Knuechel; M Page; C Kaltschmidt; P A Baeuerle; D Neumeier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

10.  Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation.

Authors:  M F Linton; J B Atkinson; S Fazio
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

View more
  112 in total

1.  Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.

Authors:  Shuang Chen; Youngho Lee; Timothy R Crother; Michael Fishbein; Wenxuan Zhang; Atilla Yilmaz; Kenichi Shimada; Danica J Schulte; Thomas J A Lehman; Prediman K Shah; Moshe Arditi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

Review 2.  Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Its Inhibitors: a Review of Physiology, Biology, and Clinical Data.

Authors:  Ashwin Durairaj; Alberto Sabates; Jonathan Nieves; Brian Moraes; Seth Baum
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 3.  Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review.

Authors:  C Roger White; David W Garber; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2014-08-25       Impact factor: 5.922

4.  Characterization of Distinct Macrophage Subpopulations during Nitrogen Mustard-Induced Lung Injury and Fibrosis.

Authors:  Alessandro Venosa; Rama Malaviya; Hyejeong Choi; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

5.  APOε4 is associated with enhanced in vivo innate immune responses in human subjects.

Authors:  Stephen C Gale; Li Gao; Carmen Mikacenic; Susette M Coyle; Nicholas Rafaels; Tanda Murray Dudenkov; Jennifer H Madenspacher; David W Draper; William Ge; Jim J Aloor; Kathleen M Azzam; Lihua Lai; Perry J Blackshear; Steven E Calvano; Kathleen C Barnes; Stephen F Lowry; Siobhan Corbett; Mark M Wurfel; Michael B Fessler
Journal:  J Allergy Clin Immunol       Date:  2014-03-18       Impact factor: 10.793

Review 6.  Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.

Authors:  Evan Dorey; Nina Chang; Qing Yan Liu; Ze Yang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

7.  The Apolipoprotein E Mimetic Peptide AEM-2 Attenuates Mitochondrial Injury And Apoptosis In Human THP-1 Macrophages.

Authors:  Samantha Giordano-Mooga; Geeta Datta; Paul Wolkowicz; David W Garber; Mayakonda Palgunachari; C Roger White; G M Anantharamaiah
Journal:  Curr Top Pept Protein Res       Date:  2018

Review 8.  ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Authors:  Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

9.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.

Authors:  P Alvarez; F Genre; M Iglesias; J J Augustin; E Tamayo; J C Escolà-Gil; B Lavín; F Blanco-Vaca; R Merino; J Merino
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

Review 10.  New strategies to treat AML: novel insights into AML survival pathways and combination therapies.

Authors:  Ramya Nair; Alejandro Salinas-Illarena; Hanna-Mari Baldauf
Journal:  Leukemia       Date:  2020-10-29       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.